Premier Alternatives

Modulo Bio

San Diego, CA · Founded 2021 · Privately Held (backing)

Developer of digital biology mechanisms designed to accelerate the discovery of therapeutic targets harnessing autoimmunity. Modulo Bio is based in San Diego, CA and was founded in 2021. It was valued at $45 million at its seed round in Nov 2024, the last priced event on record. It has raised $22.6 million across 2 recorded rounds; the latest was a $5.8 million early-stage round in Nov 2024.

PMV mark · valuation
$45.0M
Oct 2026
Priced at
its seed round
Nov 2024
Total raised
$22.6M
Last round
Early Stage VC
Nov 2024

Modulo Bio key facts

as of Oct 2026
  • Developer of digital biology mechanisms designed to accelerate the discovery of therapeutic targets harnessing autoimmunity.
  • Modulo Bio is valued at approximately $45.0M as of Oct 2026, set at its seed round, Nov 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $22.6M across 2 recorded rounds; the latest was Early Stage VC ($5.8M) in Nov 2024.
  • Notable investors include Creative Destruction Lab, Google for Startups, Mana Ventures, Calm Ventures, University of Toronto — 15 tracked in total.
  • Modulo Bio has filed 2 Form Ds with the SEC since 2021, most recently Nov 2024 ($5.8M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$45.0M

Valued at $45.0M at its seed round, Nov 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Modulo Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Modulo Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Modulo Bio funding rounds

2 rounds
Nov 2024Early Stage VC$5.8MSEC filing▮
Jun 2021Seed Round$3.9MSEC filing▮
Full funding history →

Modulo Bio valuation

Modulo Bio was valued at $45 million at its seed round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Modulo Bio raised?

Modulo Bio has raised $22.6 million in total; 2 of its rounds are on record. The largest on record was a $5.8 million early-stage round in Nov 2024.

Modulo Bio has filed 2 Form Ds with the SEC since 2021, most recently in Nov 2024 ($5.8 million sold to 3 investors).

Modulo Bio investors

15 investors are on record for Modulo Bio, including Creative Destruction Lab, Google for Startups, Mana Ventures and Calm Ventures. By type, the record holds 7 venture capital firms. The early-stage round in Nov 2024 drew 3 investors.

About Modulo Bio

Developer of digital biology mechanisms designed to accelerate the discovery of therapeutic targets harnessing autoimmunity. The company offers stem cell engineering that generates human microglia-centered neuroimmune microenvironments from stem cells to manipulate and measure the neuroimmune system in cell models and from patient samples, enabling healthcare professionals to identify new treatment paths for neurodegenerative diseases.

Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2021
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.